Ladder Capital Operating Cash Flow decreased by 117.6% to -$7.99M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 72.2%, from -$28.73M to -$7.99M. Over 2 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a 4.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $33.84M | $35.61M | $53.88M | -$30.04M | $43.98M | $38.27M | $54.49M | $111.41M | $78.12M | $58.40M | -$20.38M | $45.41M | $169.01M | -$28.73M | $44.05M | $26.34M | $45.36M | -$7.99M |
| QoQ Change | — | +5.2% | +51.3% | -155.7% | +246.4% | -13.0% | +42.4% | +104.4% | -29.9% | -25.2% | -134.9% | +322.9% | +272.2% | -117.0% | +253.3% | -40.2% | +72.2% | -117.6% |
| YoY Change | — | — | — | — | +30.0% | +7.5% | +1.1% | +470.9% | +104.1% | +7.2% | -118.3% | — | +116.4% | -41.0% | -3.0% | -84.4% | — | +72.2% |